IVI RMA GLOBAL
Tomasz Lukaszewski is an experienced medical professional specializing in reproductive medicine and gynecology. Currently serving as Interim Medical Director, Consultant in Reproductive Medicine and Gynaecology, and Co-Medical Lead at IVI RMA GLOBAL since June 2021 and as a Consultant at London Gynaecology since March 2024, Tomasz has a strong background in clinical settings, including a Clinical Fellow position at University College London Hospitals NHS Foundation Trust and previous roles at Barts Health NHS Trust and Ginekologiczno-Położniczy Szpital Kliniczny. Academic contributions include a Junior Lecturer role at Poznan University of Medical Sciences, complemented by a PhD and CCT in Obstetrics & Gynaecology from the same institution. Early career experience includes various clinical positions, including Postdoctoral Researcher at the University of Minnesota.
This person is not in any offices
IVI RMA GLOBAL
3 followers
IVIRMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field. The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world. IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer, and became a leader in fertility treatment in Europe and Latin America. RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States. IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients. • 75 Clinical Offices & 28 Labs in 9 Countries • +465 Physicians & Embryologists • +2300 Employees • +100 babies born daily thanks to IVIRMA Research & Development… • +2500 Publications • 69 Researchers • 7 Researcher centers